RedCloud to Present AI-Native Vision to Digitize and Transform Global Trade
LONDON, Sept. 19, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT)…
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the…
Databricks Launches AI Accelerator Program to Scale the Next Generation of AI Apps and Agents Startups
Backed by Databricks Ventures, the program will accelerate pre-seed and seed-stage startups…
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
September 18, 2025 16:30 ET | Source: NovaBay Pharmaceuticals Inc. EMERYVILLE, Calif.,…
UN Secretary-General appoints CEO of Naver to the UN Global Compact Board
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- UN Secretary-General António Guterres, who serves…
Aeluma Announces Proposed Public Offering of Common Stock
September 17, 2025 16:02 ET | Source: Aeluma, Inc. GOLETA, Calif., Sept.…
Funds Advised by Convergent Finance to Acquire 10.3% Stake in Knowledge Marine & Engineering Works Limited for USD 27.4 Million
Investment to be used for expansion of marine vessels fleet for business…
LANZAJET – AN EARLY MOVER IN AUSTRALIA – APPLAUDS THE AUSTRALIAN GOVERNMENT’S LEADERSHIP AND GAME-CHANGING $1.1B (AUD) INVESTMENT TO ADVANCE SUSTAINABLE FUELS
LanzaJet's Alcohol-to-Jet technology for sustainable fuel production is key to enabling the…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…